RecruitingAtrial Fibrillation

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

Eligible age

18–79 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

To evaluate the progression of atrial myopathy through wearable devices and cardiac imaging.

Sponsor: Tulane University School of Medicine

✓ Participants must meet the following criteria to be enrolled in the trial:
✓ Participants with atrial fibrillation aged 18 to 79 years old, or
✓ Participants aged 40 to 79 years old, at moderate or high risk for CVD as defined by the 10-year risk Atherosclerotic Cardiovascular Disease (ASCVD), a validated risk calculation tool.
✓ Participants who have access to internet/e-mail in their homes.
✓ Participants who have access to a compatible Android mobile device or compatible iOS mobile device (iPhone 4S or newer, iPad 3 or newer).
✓ Participants who are able and willing to return to the study clinic one-year following their baseline CMR for a follow-up appointment and 12-month CMR.
✓ Participants who are able to read, understand, and sign the consent form.

✕ Participants will be excluded from enrollment if any of the following criteria are present:
✕ Any health-related gadolinium/MRI contraindications (e.g. allergy to gadolinium, pacemakers, Implantable Cardioverter Defibrillators (ICD's), other devices/implants contraindicated for use of MRI, etc.).
✕ Participants weighing \>300 lbs. (MRI quality decreases as BMI increases).
✕ Participants with renal insufficiency (Glomerular Filtration Rate (GFR) \<30 mL per minute per 1.73 m2) or acute/severe renal dysfunction/disease.
✕ Women who are pregnant at the time of enrollment/consent. (Should a participant become pregnant during the course of the study, no CMR will be performed until 10 days, postpartum).
✕ Participants who do not have access to the internet/e-mail.
✕ Participants who do not have a compatible Android mobile device or compatible iOS mobile device (iPhone 4S or newer, iPad 3 or newer).
✕ Participants with cognitive impairments affecting their ability to be compliant with wearing and maintaining wearable devices.

New Orleans

Source: ClinicalTrials.gov · NCT04703166 · last updated 2026-05-19